Sarepta Therapeutics (SRPT) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -6.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.54% |
| Dec 31, 2025 | -3.30% |
| Sep 30, 2025 | -31.23% |
| Jun 30, 2025 | -28.89% |
| Mar 31, 2025 | 12.37% |
| Dec 31, 2024 | 33.29% |
| Sep 30, 2024 | 17.67% |
| Jun 30, 2024 | 20.31% |
| Mar 31, 2024 | 16.62% |
| Dec 31, 2023 | 15.77% |
| Sep 30, 2023 | 21.37% |
| Jun 30, 2023 | 19.73% |
| Mar 31, 2023 | 19.75% |
| Dec 31, 2022 | 31.72% |
| Sep 30, 2022 | 34.76% |
| Jun 30, 2022 | 73.32% |
| Mar 31, 2022 | 21.95% |
| Dec 31, 2021 | 32.47% |
| Sep 30, 2021 | 32.42% |
| Jun 30, 2021 | 23.76% |
| Mar 31, 2021 | 39.38% |
| Dec 31, 2020 | 58.85% |
| Sep 30, 2020 | 57.23% |
| Jun 30, 2020 | 122.71% |
| Mar 31, 2020 | 61.42% |
| Dec 31, 2019 | 47.63% |
| Sep 30, 2019 | 29.10% |
| Jun 30, 2019 | 42.50% |
| Mar 31, 2019 | 34.01% |
| Dec 31, 2018 | 26.37% |
| Sep 30, 2018 | 26.49% |
| Jun 30, 2018 | 37.16% |
| Mar 31, 2018 | -9.40% |
| Dec 31, 2017 | 8.50% |
| Sep 30, 2017 | 14.19% |
| Jun 30, 2017 | -23.51% |
| Mar 31, 2017 | 9.57% |
| Dec 31, 2016 | 23.45% |
| Sep 30, 2016 | 40.02% |
| Jun 30, 2016 | 43.36% |
| Mar 31, 2016 | 58.79% |
| Dec 31, 2015 | 72.44% |
| Sep 30, 2015 | 101.75% |
| Jun 30, 2015 | 137.98% |
| Mar 31, 2015 | 171.42% |
| Dec 31, 2014 | 104.43% |
| Sep 30, 2014 | 98.77% |
| Jun 30, 2014 | 98.25% |
| Mar 31, 2014 | 55.94% |
| Dec 31, 2013 | 79.72% |
| Sep 30, 2013 | 89.92% |